PhotoCure ASA (STU:PHS) Cyclically Adjusted Revenue per Share: €1.45 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:PHS PhotoCure ASA STU:PHS
73 GF Score
Price €4.55
GF Value €6.32
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is PhotoCure ASA Cyclically Adjusted Revenue per Share?

PhotoCure ASA STU:PHS +0.89% 73 Cyclically Adjusted Revenue per Share is €1.45 as of Jun. 2026. GuruFocus rates STU:PHS with a GF Score™ of 73/100 and a GF Value™ of €6.32 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

PhotoCure ASA's adjusted revenue per share for the three months ended in Jun. 2026 was €0.546. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €1.45 for the trailing ten years ended in Jun. 2026.

During the past 12 months, PhotoCure ASA's average Cyclically Adjusted Revenue Growth Rate was 15.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 14.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 14.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of PhotoCure ASA was 14.90% per year. The lowest was 8.40% per year. And the median was 12.45% per year.

As of today (2026-08-07), PhotoCure ASA's current stock price is €4.545. PhotoCure ASA's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was €1.45. PhotoCure ASA's Cyclically Adjusted PS Ratio of today is 3.13.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PhotoCure ASA was 17.97. The lowest was 3.04. And the median was 5.67.


PhotoCure ASA  (STU:PHS) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

PhotoCure ASA's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=4.545/1.45
=3.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PhotoCure ASA was 17.97. The lowest was 3.04. And the median was 5.67.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


PhotoCure ASA Cyclically Adjusted Revenue per Share Related Terms


PhotoCure ASA Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for PhotoCure ASA's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PhotoCure ASA Cyclically Adjusted Revenue per Share Chart

PhotoCure ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.88 0.97 1.06 1.17 1.25

PhotoCure ASA Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.18 1.25 1.25 1.40 1.45

STU:PHS vs ZTS, UTHR, VTRS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PhotoCure ASA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PhotoCure ASA Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PhotoCure ASA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where PhotoCure ASA's Cyclically Adjusted PS Ratio falls into.


STU:PHS
73GF Score
PhotoCure ASA STU:PHS
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PhotoCure ASA Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PhotoCure ASA's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.546/141.5800*141.5800
=0.546

Current CPI (Jun. 2026) = 141.5800.

PhotoCure ASA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.178 104.200 0.242
201612 0.193 104.400 0.262
201703 0.185 105.000 0.249
201706 0.194 105.800 0.260
201709 0.178 105.900 0.238
201712 0.184 106.100 0.246
201803 0.201 107.300 0.265
201806 0.225 108.500 0.294
201809 0.213 109.500 0.275
201812 0.231 109.800 0.298
201903 0.251 110.400 0.322
201906 0.253 110.600 0.324
201909 0.288 111.100 0.367
201912 0.529 111.300 0.673
202003 0.222 111.200 0.283
202006 0.212 112.100 0.268
202009 0.172 112.900 0.216
202012 0.346 112.900 0.434
202103 0.327 114.600 0.404
202106 0.336 115.300 0.413
202109 0.317 117.500 0.382
202112 0.358 118.900 0.426
202203 0.313 119.800 0.370
202206 0.360 122.600 0.416
202209 0.390 125.600 0.440
202212 0.367 125.900 0.413
202303 0.347 127.600 0.385
202306 0.458 130.400 0.497
202309 0.353 129.800 0.385
202312 0.432 131.900 0.464
202403 0.378 132.600 0.404
202406 0.464 133.800 0.491
202409 0.382 133.700 0.405
202412 0.587 134.800 0.617
202503 0.405 136.100 0.421
202506 0.433 137.800 0.445
202509 0.436 138.500 0.446
202512 0.436 139.100 0.444
202603 0.885 141.030 0.888
202606 0.546 141.580 0.546

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €1.45 mean?
PhotoCure ASA (STU:PHS) has a Cyclically Adjusted Revenue per Share of €1.45 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on PhotoCure ASA and its competitors.
Is PhotoCure ASA's Cyclically Adjusted Revenue per Share too high?
PhotoCure ASA's current Cyclically Adjusted Revenue per Share is €1.45. Overall, PhotoCure ASA has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PhotoCure ASA's Cyclically Adjusted Revenue per Share compare to ZTS and UTHR?
PhotoCure ASA's Cyclically Adjusted Revenue per Share of €1.45 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on PhotoCure ASA and its competitors. PhotoCure ASA's current Cyclically Adjusted Revenue per Share is €1.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PhotoCure ASA stock overvalued right now?
Based on GuruFocus' analysis, PhotoCure ASA (STU:PHS) is currently considered Modestly Undervalued. The stock's GF Value™ is €6.32, compared to a current price of €4.55 — trading 28.1% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €1.45. PhotoCure ASA's overall GF Score™ is 73/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For PhotoCure ASA (STU:PHS), the current Cyclically Adjusted Revenue per Share is €1.45 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PhotoCure ASA (STU:PHS) Overvalued in 2026?

Based on GuruFocus' analysis, PhotoCure ASA stock appears to be undervalued. The current stock price of €4.55 is trading 28.1% below its estimated GF Value™ of €6.32. GuruFocus considers PhotoCure ASA to be Modestly Undervalued.

Key valuation signals for STU:PHS:

  • Cyclically Adjusted Revenue per Share: €1.45
  • GF Value™: €6.32 vs. price of €4.55 (28.1% below fair value)
  • GF Score™: 73/100 with 1 warning sign

No single metric tells the full story. See the STU:PHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PhotoCure ASA Business Description

Address Hoffsveien 4, Oslo, NOR, 0275
PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products and specialty pharmaceutical companies. The technology platform of the company is focused on the field of photodynamic diagnosis and treatment of cancer. The company has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, BeNeLux, Italy, Other European countries, Canada, and the United States.
73GF Score

Get the complete analysis for STU:PHS

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.55
Price
€6.32
GF Value